Emergent Biosolutions Inc (EBS) stock is lower by -49.29% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives EBS stock a score of 29 out of a possible 100. That rank is influenced by a short-term technical score of 2. EBS's rank also includes a long-term technical score of 5. The fundamental score for EBS is 80. In addition to the average rating from Wall Street analysts, EBS stock has a mean target price of $91.17. This means analysts expect the stock to increase 69.77% over the next 12 months.
EBS has an Overall Score of 29. Find out what this means to you and get the rest of the rankings on EBS!